These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 33647365)

  • 1. Short-term direct oral anticoagulation or dual antiplatelet therapy following left atrial appendage closure in patients with relative contraindications to chronic anticoagulation therapy.
    Faroux L; Cruz-González I; Arzamendi D; Freixa X; Nombela-Franco L; Peral V; Caneiro-Queija B; Mangieri A; Trejo-Velasco B; Asmarats L; Regueiro A; McInerney A; Mas-Lladó C; Estevez-Loureiro R; Laricchia A; O'Hara G; Rodés-Cabau J
    Int J Cardiol; 2021 Jun; 333():77-82. PubMed ID: 33647365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DAPT Is Comparable to OAC Following LAAC With WATCHMAN FLX: A National Registry Analysis.
    Coylewright M; Holmes DR; Kapadia SR; Hsu JC; Gibson DN; Freeman JV; Yeh RW; Piccini JP; Price MJ; Allocco DJ; Nair DG
    JACC Cardiovasc Interv; 2023 Nov; 16(22):2708-2718. PubMed ID: 37943200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual antiplatelet therapy is safe and efficient after left atrial appendage closure.
    Maksym J; Mazurek T; Kochman J; Grygier M; Kapłon-Cieślicka A; Marchel M; Lodziński P; Piątkowski R; Wilimski R; Czub P; Fojt A; Karolczak N; Hendzel P; Opolski G
    Kardiol Pol; 2018; 76(2):459-463. PubMed ID: 29350390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: The ADALA Randomized Clinical Trial.
    Freixa X; Cruz-González I; Cepas-Guillén P; Millán X; Antúnez-Muiños P; Flores-Umanzor E; Asmarats L; Regueiro A; López-Tejero S; Li CP; Sanchis L; Rodés-Cabau J; Arzamendi D
    JAMA Cardiol; 2024 Oct; 9(10):922-926. PubMed ID: 39110427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial appendage closure: a new strategy for cardioembolic events despite oral anticoagulation.
    Falasconi G; Gaspardone C; Godino C; Gaspardone A; Radinovic A; Pannone L; Leo G; Posteraro GA; Slavich M; Melillo F; Marzi A; D'Angelo G; Limite LR; Frontera A; Brugliera L; Agricola E; Margonato A; Della Bella P; Mazzone P
    Panminerva Med; 2023 Jun; 65(2):227-233. PubMed ID: 34664480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term antiplatelet versus anticoagulant therapy after left atrial appendage closure: a systematic review and meta-analysis.
    Zhou Q; Liu X; Gu ZC; Yang X; Huang XH; Wu YZ; Tao YY; Wei M
    J Thromb Thrombolysis; 2024 Feb; 57(2):194-203. PubMed ID: 38180590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propensity-matched comparison of antiplatelet versus anticoagulant after left atrial appendage closure with the Watchman.
    Liu XX; Kleinecke C; Busch S; Allakkis W; Mohrez Y; Cheikh-Ibrahim M; Mahnkopf C; Brachmann J; Schnupp S; Gloekler S; Yu J; Ma C
    Pacing Clin Electrophysiol; 2020 Nov; 43(11):1242-1251. PubMed ID: 32779203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure.
    Asmarats L; O'Hara G; Champagne J; Paradis JM; Bernier M; O'Connor K; Beaudoin J; Junquera L; Del Val D; Muntané-Carol G; Côté M; Rodés-Cabau J
    Circ Cardiovasc Interv; 2020 Aug; 13(8):e009039. PubMed ID: 32772571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Glomerular Filtration Rates on Outcomes Following Percutaneous Left Atrial Appendage Closure.
    Faroux L; Cruz-González I; Arzamendi D; Freixa X; Nombela-Franco L; Peral V; Caneiro-Queija B; Mangieri A; Trejo-Velasco B; Asmarats L; Regueiro A; McInerney A; Mas-Lladó C; Estevez-Loureiro R; Laricchia A; O'Hara G; Rodés-Cabau J
    Am J Cardiol; 2021 Apr; 145():77-84. PubMed ID: 33508268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of catheter-based left atrial appendage closure in patients with contraindications for long-term anticoagulation.
    Seidel A; Parwani AS; Krackhardt F; Huemer M; Attanasio P; Haverkamp W; Pieske B; Boldt LH
    Minerva Cardioangiol; 2017 Dec; 65(6):545-552. PubMed ID: 28565887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latest outcomes of transcatheter left atrial appendage closure devices and direct oral anticoagulant therapy in patients with atrial fibrillation over the past 5 years: a systematic review and meta-analysis.
    Takeda K; Tsuboko Y; Iwasaki K
    Cardiovasc Interv Ther; 2022 Oct; 37(4):725-738. PubMed ID: 35098478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Looking for optimal antithrombotic strategy after transcatheter left atrial appendage occlusion: a real-world comparison of different antiplatelet regimens.
    Vignali L; Gurgoglione FL; Barocelli F; Cattabiani MA; Solinas E; Maini A; Tadonio I; Benatti G; Pelà G; Coli S; Ardissino D; Niccoli G
    Int J Cardiol; 2023 Jan; 371():92-99. PubMed ID: 36181948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: ADRIFT a Randomized Pilot Study.
    Duthoit G; Silvain J; Marijon E; Ducrocq G; Lepillier A; Frere C; Dimby SF; Popovic B; Lellouche N; Martin-Toutain I; Spaulding C; Brochet E; Attias D; Mansourati J; Lorgis L; Klug D; Zannad N; Hauguel-Moreau M; Braik N; Deltour S; Ceccaldi A; Wang H; Hammoudi N; Brugier D; Vicaut E; Juliard JM; Montalescot G
    Circ Cardiovasc Interv; 2020 Jul; 13(7):e008481. PubMed ID: 32674675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation.
    Dognin N; Salaun E; Champagne C; Domain G; O'Hara G; Philippon F; Paradis JM; Faroux L; Beaudoin J; O'Connor K; Bernier M; Rodés-Cabau J; Champagne J
    J Interv Card Electrophysiol; 2022 Aug; 64(2):497-509. PubMed ID: 34822043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy.
    Urena M; Rodés-Cabau J; Freixa X; Saw J; Webb JG; Freeman M; Horlick E; Osten M; Chan A; Marquis JF; Champagne J; Ibrahim R
    J Am Coll Cardiol; 2013 Jul; 62(2):96-102. PubMed ID: 23665098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual stroke risk after left atrial appendage closure in patients with prior oral anticoagulation failure.
    Pracoń R; Zieliński K; Bangalore S; Konka M; Kruk M; Kępka C; Trochimiuk P; Dębski M; Przyłuski J; Kaczmarska E; Dzielińska Z; Kurowski A; Witkowski A; Demkow M
    Int J Cardiol; 2022 May; 354():17-21. PubMed ID: 35219744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation Alone vs Anticoagulation Plus Aspirin or DAPT Following Left Atrial Appendage Occlusion.
    Reinhardt SW; Gibson DN; Hsu JC; Kapadia SR; Yeh RW; Price MJ; Piccini JP; Nair DG; Christen T; Allocco DJ; Freeman JV
    J Am Coll Cardiol; 2024 Sep; 84(10):889-900. PubMed ID: 39197978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation.
    Black-Maier E; Piccini JP; Granger CB
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2968-2976. PubMed ID: 31520437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.